Concorde Asset Management, LLC

Position in PFE — Pfizer Inc

CIK 1631773 ANN ARBOR, MI

Position in PFE

as of Jun 30, 2026 · filed Aug 18, 2026 Compact

Position Value

$309,018

+$71,602 QoQ

Shares Held

12,833

+51.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#2,105

of 2,820 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concorde Asset Management, LLC holds $2,975,283 across 6 Drug Manufacturers - General names. PFE ranks #5 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	652	$782,028
2	JNJ	Johnson & Johnson	2,819	$715,941
3	ABBV	AbbVie Inc.	2,581	$649,482
4	AMGN	Amgen Inc	856	$309,974
5	PFE	Pfizer Inc This page	12,833	$309,018
6	GILD	Gilead Sciences, Inc.	1,653	$208,840

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$309,018	12,833	+51.8%	Shares	Sole	2026-08-18
2026-03-31	$237,416	8,455	+75.1%	Shares	Sole	2026-06-01
2022-12-31	$247,489	4,830	+1.0%	Shares	Sole	2023-02-02
2022-09-30	$209,216	4,781	-10.2%	Shares	Sole	2022-10-31
2022-03-31	$275,777	5,327	+22.5%	Shares	Sole	2022-04-22
2021-12-31	$256,807	4,349	-41.8%	Shares	Sole	2022-02-02
2021-03-31	$270,890	7,477	-7.5%	Shares	Sole	2021-04-27
2020-12-31	$297,461	8,081	-2.1%	Shares	Sole	2021-01-29
2020-09-30	$303,030	8,257	-23.8%	Shares	Sole	2020-10-23
2020-06-30	$354,304	10,835	-2.2%	Shares	Sole	2020-07-20
2020-03-31	$361,714	11,082	—	Shares	Sole	2020-04-22
No filing history on record for this holder in this stock.